Skip to search formSkip to main contentSkip to account menu

TCV 116

Known as: TCV-116 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

candesartan cilexetil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study.
2007
2007
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis
Background and Aim:  The molecular mechanisms underlying the involvement of the renin‐angiotensin system in hepatic fibrosis are… 
Highly Cited
2006
Highly Cited
2006
N- and P-channel transport behavior in thin film transistors based on tricyanovinyl-capped oligothiophenes.
We report the structural and electrical characterization of thin films of organic semiconductor molecules consisting of an… 
2002
2002
TCV-116, an angiotensin II type 1 receptor antagonist, reduces hepatic ischemia-reperfusion injury in rats
Background. In Pringle’s maneuver during liver surgery and liver transplantation, ischemia–reperfusion (I/R) is an unavoidable… 
2000
2000
Effects of the AT1 receptor antagonist on adhesion molecule expression in leukocytes and brain microvessels of stroke-prone spontaneously hypertensive rats.
Highly Cited
1996
Highly Cited
1996
Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
BACKGROUND Despite the current progress in immunosuppressive regimens, the incidence of graft coronary artery disease (CAD) after… 
1994
1994
TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation.
OBJECTIVE The objective of this study was to determine the renal protective effects of TCV 116, a novel, non-competitive… 
1993
1993
Pilot study of a new angiotensin II receptor antagonist, TCV-116: effects of a single oral dose on blood pressure in patients with essential hypertension.
After a 1-week placebo control period, six hypertensive patients (mean age, 67 years) each received single doses of 1, 2.5, and 5… 
1993
1993
Peripheral vs. central blockade of the renin-angiotensin system in spontaneously hypertensive rats: comparison of novel AT1 receptor antagonist TCV-116 with angiotensin converting enzyme inhibitor…
In the present study, we evaluated the hemodynamic and metabolic profiles derived from oral administration of the angiotensin… 
1993
1993
Asp-->Asn substitutions in the putative calcium-binding site of the turnip crinkle virus coat protein affect virus movement in plants.
Many plant virus coat proteins have binding sites for divalent cations, particularly calcium. It has been speculated that the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)